Recent Posts
- PADAGIS BELLADONNA AND OPIUM SUPPOSITORIES CII
- PADAGIS ANNOUNCES THE LAUNCH OF BRINZOLAMIDE OPHTHALMIC SUSPENSION WITH CGT EXCLUSIVITY
- PADAGIS ANNOUNCES THE FIRST LAUNCH OF AN OVER-THE-COUNTER NALOXONE NASAL SPRAY IN THE UNITED STATES
- Padagis announces the acquisition of 17,000 square meter facility in Yerucham, Israel
- PADAGIS ANNOUNCES TWO FIRST-TO-FILE ANDA SUBMISSIONS
Recent Comments